US · MLAB
Mesa Laboratories, Inc.
- Sector
- Technology · Hardware, Equipment & Parts
- Headquarters
- Lakewood, CO 80228
- Website
- mesalabs.com
Price · as of 2025-03-31
$103.31
Market cap 533.53M
Valuation summary
Four models, one snapshot. Upside is target ÷ current − 1.
| Valuation method | Value, $ | Upside, % |
|---|---|---|
| Artificial Intelligence(AI) | $102.73 | -0.56% |
| Intrinsic Value(DCF) | $52.89 | -48.8% |
| Graham-Dodd Method(GD) | — | — |
| Graham Formula(GF) | — | — |
Valuation history
Annual price (USD per share) overlaid with each model's fair value. Y-axis is log scale.
| Year | Price | AI | DCF | Graham-Dodd | Graham Formula |
|---|---|---|---|---|---|
| 2011 | $28.42 | $67.64 | $195.54 | $9.46 | $106.35 |
| 2012 | $41.67 | $74.20 | $212.98 | $13.51 | $67.10 |
| 2013 | $49.28 | $99.78 | $271.47 | $13.15 | $61.88 |
| 2014 | $73.32 | $74.01 | $116.29 | $12.09 | $55.23 |
| 2015 | $87.64 | $116.10 | $301.77 | $12.44 | $113.77 |
| 2016 | $117.57 | $106.14 | $173.55 | $11.05 | $80.31 |
| 2017 | $137.13 | $300.29 | $92.13 | $12.57 | $55.53 |
| 2018 | $187.43 | $120.70 | $0.00 | $0.00 | $0.00 |
| 2019 | $195.82 | $202.85 | $0.00 | $11.83 | $29.28 |
| 2020 | $240.83 | $212.53 | $21.60 | $11.08 | $9.19 |
| 2021 | $258.07 | $185.44 | $47.59 | $43.07 | $14.04 |
| 2022 | $197.50 | $159.26 | $82.20 | $11.88 | $15.83 |
| 2023 | $128.81 | $173.18 | $44.60 | $11.39 | $4.56 |
| 2024 | $103.62 | $6,151.11 | $0.00 | $0.00 | $0.00 |
| 2025 | $103.36 | $102.73 | $18.89 | $0.00 | $0.00 |
AI valuation
Our deep-learning model estimates Mesa Laboratories, Inc.'s (MLAB) per-share fair value from quarterly fundamentals, sector trend, and historical valuation patterns.
- AI fair value
- $102.73
- Current price
- $103.31
- AI upside
- -0.56%
Methodology and confidence bands appear in the dedicated valuation theory section. The AI score is an estimate, not a recommendation.
Intrinsic value (DCF)
Open DCF calculatorThree textbook valuation models, recomputed daily from the latest financial statements. The DCF uses our Chepakovich model. Graham-Dodd and Graham Formula are conservative reference points.
DCF
$52.89
-48.8% upside
Graham-Dodd
—
— upside
Graham Formula
—
— upside
Peer comparison
Same-industry comparables, ranked by market cap.
| Basic Info | Model Valuation | Core Valuation | Profitability | Leverage & Liquidity | Growth | Cash Flow | Dividends | Enterprise Value | Risk | ||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ticker | Company Name | Price | Market Cap | AI Upside | DCF Upside | GD Upside | GF Upside | P/E | P/B | P/S | EV/EBITDA | PEG | P/TBV | Gross Margin | Operating Margin | Net Margin | ROE | ROIC | ROA | Debt/Equity | Interest Coverage | Current Ratio | Quick Ratio | Net Debt/EBITDA | EPS Growth | Sales Growth | FCF Growth | FCF Yield | Op Cash Flow Ratio | Cash ROIC | Dividend Yield | Dividend Payout | Shareholder Yield | EV/EBIT | EV/FCF | EV/Sales | Altman Z-Score |
| MLAB | Mesa Laboratories, Inc. | $103.31 | 533.53M | -1% | -49% | — | — | -284.28 | 3.51 | 2.33 | 16.89 | — | -4.72 | 62.61% | 6.78% | -0.82% | -1.29% | 1.97% | -0.45% | 1.14 | 1.38 | 0.63 | 0.42 | 3.64 | -9924.00% | 1147.00% | 179.00% | 7.54% | 0.29 | 12.77% | 0.62% | -175.70% | 9.34% | 43.79 | 16.91 | 2.97 | 1.13 |
| BZAI | Blaize Holdings, Inc. | $1.18 | 144.01M | +3,919% | +92% | — | +2,394% | -5.48 | 13.84 | 215.83 | -7.21 | — | 13.84 | 62.74% | -3065.32% | -3937.90% | -220.96% | -120.08% | -101.22% | 0.06 | — | 0.05 | 0.00 | -0.03 | -40682.00% | -5970.00% | 223088.00% | -16.23% | -3.82 | -139.35% | 0.00% | 0.00% | 5.88% | -7.07 | -6.19 | 216.79 | 4.13 |
| EGAN | eGain Corporation | $9.34 | 255.79M | +373% | -56% | -13% | -57% | 5.68 | 2.27 | 2.07 | 20.71 | 1.61 | 2.71 | 70.12% | 5.01% | 36.47% | 46.33% | 64.43% | 23.32% | 0.05 | — | 1.60 | 1.54 | -9.91 | 35200.00% | -471.00% | -6167.00% | 2.57% | 0.08 | 68.28% | 0.00% | 0.00% | 8.62% | 27.93 | 26.35 | 1.40 | -0.13 |
| GDEV | GDEV Inc. | $15.04 | 272.68M | +291% | -57% | -91% | — | 10.51 | -2.64 | 0.64 | 3.68 | — | -2.49 | 66.26% | 9.62% | 6.07% | -25.36% | -14.09% | 8.62% | -0.01 | 94.40 | 0.68 | 0.66 | -2.99 | -4000.00% | -939.00% | 6331.00% | 10.47% | 0.11 | -11.50% | 0.00% | 0.00% | 27.39% | 3.33 | 4.80 | 0.32 | 0.82 |
| GRRR | Gorilla Technology Group … | $11.82 | 159.26M | +368% | +868% | — | — | -4.54 | 4.11 | 4.02 | -4.45 | — | 4.28 | 49.96% | -89.65% | -86.77% | -103.89% | -118.47% | -49.11% | 0.30 | -91.39 | 1.68 | 1.30 | -0.01 | -47378.00% | 1542.00% | 13486.00% | -10.36% | -0.39 | -56.16% | 0.00% | 0.00% | 10.23% | -4.26 | -9.16 | 3.82 | 0.33 |
| GRVY | Gravity Co., Ltd. | $65.02 | 451.82M | +3% | -6% | +56% | — | 6.52 | 0.97 | 1.10 | -0.06 | — | 0.99 | 38.72% | 17.05% | 16.96% | 16.47% | 2612.23% | 13.43% | 0.00 | 632.47 | 6.02 | 5.91 | -1.98 | -3567.00% | -3097.00% | -4173.00% | 13.34% | 0.72 | 2827.90% | 0.00% | 0.00% | 8.10% | -0.08 | -0.09 | -0.01 | 5.95 |
| LPTH | LightPath Technologies, I… | $10.43 | 455.02M | +5,981% | +2,376% | — | — | -15.58 | 14.81 | 6.23 | -49.26 | -21.81 | -16.44 | 27.23% | -31.78% | -39.98% | -64.89% | -37.51% | -22.95% | 0.97 | -10.57 | 1.66 | 0.84 | -2.10 | 7143.00% | 1726.00% | 47732.00% | -4.14% | -0.49 | -30.44% | 0.00% | 0.00% | 0.00% | -20.47 | -25.23 | 6.51 | -1.71 |
| MVIS | MicroVision, Inc. | $0.78 | 238.55M | +3,451% | -41% | — | +1,424% | -2.51 | 4.98 | 51.75 | -3.10 | -112.85 | 6.43 | -60.35% | -1821.10% | -2063.78% | -134.07% | -272.49% | -77.29% | 1.06 | -19.19 | 1.79 | 1.65 | 0.04 | 222.00% | -3531.00% | -16.00% | -28.36% | -1.49 | -219.58% | 0.00% | 0.00% | 0.00% | -2.57 | -3.19 | 46.84 | -9.88 |
| PUBM | PubMatic, Inc. | $8.10 | 383.94M | +367% | -45% | -58% | — | -26.59 | 1.46 | 1.36 | 10.17 | — | 1.67 | 63.56% | -6.10% | -5.11% | -5.36% | -9.12% | -2.04% | 0.17 | — | 1.39 | 1.34 | -3.65 | -23478.00% | -286.00% | 9117.00% | 17.35% | 0.22 | 38.90% | 0.00% | 0.00% | 12.67% | -16.39 | 4.24 | 1.00 | 1.42 |
| VPG | Vishay Precision Group, I… | $46.07 | 611.77M | +76% | -57% | -48% | -93% | 123.32 | 1.94 | 2.12 | 23.61 | — | 2.60 | 38.88% | 3.19% | 1.72% | 1.61% | 1.95% | 1.17% | 0.19 | 5.06 | 4.47 | 2.60 | -0.88 | -4595.00% | 22.00% | -4038.00% | 0.97% | 0.26 | 2.08% | 0.00% | 0.00% | 0.01% | 64.27 | 99.10 | 2.05 | 5.13 |
| XRX | Xerox Holdings Corporatio… | $1.80 | 231.48M | +668% | -13% | — | — | -0.22 | 0.35 | 0.03 | -25.26 | — | -0.09 | 36.83% | -0.94% | -14.65% | -105.65% | -1.52% | -11.32% | 6.45 | -0.27 | 1.12 | 0.69 | -23.79 | -2298.00% | 1288.00% | -4454.00% | 112.38% | 0.11 | 5.96% | 30.81% | -6.90% | 30.81% | -60.08 | 15.31 | 0.56 | 1.10 |
About Mesa Laboratories, Inc.
Mesa Laboratories, Inc. develops, manufactures, and sells life sciences tools and quality control products and services in the United States, Europe, the Asia Pacific, and internationally. The company's Sterilization and Disinfection Control segment manufactures and sells biological, cleaning, and chemical indicators that are used to assess the effectiveness of sterilization and disinfection processes in the hospital, dental, medical device, and pharmaceutical industries. This segment also provides testing and laboratory services primarily to the dental industry. Its Biopharmaceutical Development segment develops, manufactures, and sells automated systems for protein analysis (immunoassays) and peptide synthesis solutions. This segment's solutions include protein analysis comprising analysis equipment, CDs, kits, and buffers; and peptide synthesizers that enables to automate chemically synthesized peptides that are used in the creation of peptide therapies, biomaterials, cosmetics, and general research. The company's Calibration Solutions segment designs, manufactures, and markets quality control and calibration products to measure or calibrate temperature, pressure, pH, humidity, and other such parameters used for health and safety purposes in the hospital, medical device manufacturing, pharmaceutical manufacturing, and various laboratory and healthcare environments. This segment's products include continuous monitoring systems, dialysate meters and consumables, data loggers, gas flow calibration and air sampling equipment, and torque testing systems. Its Clinical Genomics segment develops, manufactures, and sells genetic analysis tools that include MassARRAY system and consumables, including chips, panels, and chemical reagent solutions used by clinical labs to perform genomic clinical testing in several therapeutic areas, such as newborn screenings, pharmacogenetics, and oncology. The company was incorporated in 1982 and is headquartered in Lakewood, Colorado.
- CEO
- Gary Owens
- Employees
- 736
- Beta
- 0.89
Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Upside computed as ($52.89 ÷ $103.31) − 1 = -48.8% (DCF, example).